To: Mohan Marette who wrote (3690 ) 2/9/1999 8:23:00 PM From: Mohan Marette Respond to of 12475
Dabur scrip vaults 50% in '99, beats FMCG majors Javed Sayed New Delhi 9 February DESI Dabur has outperformed most fast moving consumer goods (FMCG) multinationals on the bourses in the new calendar year. The Dabur India scrip has shot up by over Rs 200 in 1999 and the scrip which ended December 31, 1998 on Rs 426 at the BSE closed at Rs 637 on February 8, 1999, an increase of over 50 per cent. A comparison with the share prices of some leading FMCG multinationals for the same period reveals, with the exception of Hindustan Lever Ltd (HLL), no other company has witnessed a Rs 200 rise in its share price. The HLL share price has gone up to Rs 1,872 on February 8, from Rs 1,663.50 on December 31, 1998; Reckitt & Colman share price to Rs 437.25 from Rs 375.25;<b. Procter & Gamble scrip to Rs 857.75 from Rs 792 and Smithkline Beecham Consumer Healthcare price to Rs 663.50 from Rs 525.50. In the same period, Colgate 's scrip fell to Rs 169.60 from Rs 196. In the December 31-February 8 period, while HLL has beaten Dabur in absolute terms, in percentage terms, the Dabur stock has risen more than the HLL stock as well as that of other FMCG majors. Dabur scrip touched a 52-week high of Rs 683 on last Friday. Its 52-week low is Rs 180. The company has a share capital of Rs 28.50 crore with 2.85 crore shares. Its market capitalisation has gone up to Rs 1,850 crore on February 8, from Rs 1,225 crore on December 31. The promoters, the Burman family, have a 79 per cent holding in the company and at current market price, the market value of their shares is in the region of Rs 1,500 crore. Dabur share price began its steady upward march from July 1 from the Rs 240 level. The scrip crossed Rs 400 in December before jumping to Rs 500 in January and then breached the Rs 600-mark in February. Company officials attribute the surge to trading of the scrip among domestic institutions and FIIs, following a re-rating of the company by the fund managers. According to company sources, Dabur's attempt to restructure and re-position itself as a professionally managed FMCG company from a family-run diversified company has been noticed by the funds managers. The company was previously treated as a diversified or a pharmaceutical company and only now is it being recognised as an FMCG company. This, company officials claim, is the result of several initiatives undertaken by Dabur in 1998. These include the decision to divest from non-core areas and concentrate resources on fewer brands in the food, personal care, healthcare and anti-cancer areas. The Burmans have also decided to step back from the daily management of the company and leave the day-to-day running to a team of professionals led by a chief executive officer. The net profit of Dabur India has increased by five per cent to Rs 37.53 crore for the nine-month period ended December 31, 1998 from Rs 36.01 crore and its net sales increased by 13 per cent to Rs 700 crore.